{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:37:29Z","timestamp":1791859049099,"version":"4.3.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T00:00:00Z","timestamp":1721347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T00:00:00Z","timestamp":1721347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002352","name":"Ain Shams University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002352","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>To evaluate the safety and efficacy of L-glutamine in reducing vaso-occlusive crisis (VOC) and improving cerebral arterial blood flow in children with sickle cell disease (SCD). This is an interventional randomized controlled trial that recruited sixty SCD patients, aged 9.2\u2009\u00b1\u20093.7 years, who had at least two VOCs during the last 12 months and on a stable dose of hydroxyurea. They were randomly assigned in a 1:1 ratio to receive glutamine (0.3 gm\/kg\/dose\/12h) orally for 24 weeks or the standard of care (SOC). All patients had VOCs in the last year\u2009&gt;\u20093, those on glutamine had a higher number of VOCs and hospitalization for VOC in the last year. There was a decreasing trend in the number, severity, and hospitalization of VOC and a significantly lower cumulative number of VOCs and hospitalizations in the glutamine group than in SOC (p\u2009=\u20090.008, p\u2009&lt;\u20090.001 respectively). Time-averaged mean maximum velocity for the glutamine group had a marginal increase in both middle cerebral arteries, all values remained normal within a normal range, and in both internal carotid arteries, values increased from abnormally low to normal ranges at week 24. Glutamine reduced the number of VOCs and severity and may have a potentially favorable impact on the cerebral arterial flow velocities.<\/jats:p>","DOI":"10.1007\/s00277-024-05877-8","type":"journal-article","created":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T03:02:41Z","timestamp":1721358161000},"page":"3493-3506","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Safety and efficacy of L-Glutamine in reducing the frequency of acute complications among patients with sickle cell disease: A randomized controlled study"],"prefix":"10.1007","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3761-6373","authenticated-orcid":false,"given":"Fatma Soliman Elsayed","family":"Ebeid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nihal Hussien","family":"Aly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naglaa Mohammed","family":"Shaheen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samah Mohammed Ahmed","family":"Abdellatif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Ashraf Mahmoud","family":"Okba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada Ayman","family":"Gad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Mostafa","family":"Makkeyah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,19]]},"reference":[{"issue":"9757","key":"5877_CR1","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","volume":"376","author":"DC Rees","year":"2010","unstructured":"Rees DC, Williams TN, Gladwin MT (2010) Sickle-cell disease. Lancet 376(9757):2018\u20132031","journal-title":"Lancet"},{"issue":"1","key":"5877_CR2","doi-asserted-by":"publisher","first-page":"R104","DOI":"10.1152\/ajpregu.00021.2018","volume":"315","author":"K Gupta","year":"2018","unstructured":"Gupta K, Jahagirdar O, Gupta K (2018) Targeting pain at its source in sickle cell disease. Am J Physiol Regul Integr Comp Physiol 315(1):R104\u2013R112","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"14","key":"5877_CR3","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1146\/annurev-pathmechdis-012418-012838","volume":"24","author":"P Sundd","year":"2019","unstructured":"Sundd P, Gladwin MT, Novelli EM (2019) Pathophysiology of Sickle Cell Disease. Annu Rev Pathol 24(14):263\u2013292","journal-title":"Annu Rev Pathol"},{"issue":"11","key":"5877_CR4","doi-asserted-by":"crossref","first-page":"204062072095500","DOI":"10.1177\/2040620720955000","volume":"29","author":"I Osunkwo","year":"2020","unstructured":"Osunkwo I, Manwani D, Kanter J (2020) Current and novel therapies for the prevention of vaso-occlusive crisis in sickle cell disease. Ther Adv Hematol 29(11):2040620720955000","journal-title":"Ther Adv Hematol"},{"key":"5877_CR5","doi-asserted-by":"publisher","unstructured":"Sagi V, Mittal A, Tran H, Gupta K (2021) Pain in sickle cell disease: current and potential translational therapies. Transl Res 234:141\u2013158. https:\/\/doi.org\/10.1016\/j.trsl.2021.03.007","DOI":"10.1016\/j.trsl.2021.03.007"},{"issue":"4","key":"5877_CR6","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1358\/dot.2020.56.4.3110575","volume":"56","author":"SE Cox","year":"2020","unstructured":"Cox SE, Hart E, Kirkham FJ, Stotesbury H (2020) L-Glutamine in sickle cell disease. Drugs Today (Barc) 56(4):257\u2013268","journal-title":"Drugs Today (Barc)"},{"key":"5877_CR7","doi-asserted-by":"publisher","unstructured":"Niihara Y, Miller ST, Kanter J, Lanzkron S, Smith WR, Hsu LL, Gordeuk VR, Viswanathan K, Sarnaik S, Osunkwo I, Guillaume E, Sadanandan S, Sieger L, Lasky JL, Panosyan EH,\u00a0Blake OA, New TN, Bellevue R, Tran LT, Razon RL, Stark CW, Neumayr LD, Vichinsky EP, Investigators of the Phase 3 Trial of l-Glutamine in Sickle Cell Disease (2018) A phase 3 trial of l-Glutamine in sickle cell disease. N Engl J Med 379(3):226\u2013235. https:\/\/doi.org\/10.1056\/NEJMoa1715971","DOI":"10.1056\/NEJMoa1715971"},{"key":"5877_CR8","unstructured":"Food and Administration, Approval (2018) FDA approved l-glutamine powder for the treatment of sickle cell disease. https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approved-l-glutamine-powder-treatment-sickle-cell-disease#:~:text=On%20July%207%2C%202017%2C%20the%20U.S.%20Food%20and,adult%20and%20pediatric%20patients%205%20years%20and%20older. Accessed 12 Jan 2024"},{"key":"5877_CR9","unstructured":"Bender Ma and Carlberg K (2003) Sickle Cell Disease. Gene Reviews; Seattle (WA): University of Washington, Seattle; 1993. 2003"},{"key":"5877_CR10","doi-asserted-by":"publisher","first-page":"116","DOI":"10.4172\/2167-065X.1000116","volume":"3","author":"Y Niihara","year":"2014","unstructured":"Niihara Y, Macan H, Eckman JR, Koh H, Cooper ML, Ziegler T, Razon R, Tanaka K, Stark CW, Johnson CS (2014) L-Glutamine Therapy Reduces Hospitalization for Sickle Cell Anemia and Sickle \u03b2\u00b0-Thalassemia Patients at Six Months \u2013 A Phase II Randomized Trial. Clin Pharmacol Biopharm 3:116","journal-title":"Clin Pharmacol Biopharm"},{"key":"5877_CR11","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1177\/1535370219900637","volume":"245","author":"A Sadaf","year":"2020","unstructured":"Sadaf A, Quinn CT (2020) L-glutamine for sickle cell disease: Knight or pawn? Exp Biol Med (Maywood) 245:146\u2013154","journal-title":"Exp Biol Med (Maywood)"},{"issue":"8","key":"5877_CR12","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1002\/pbc.24491","volume":"60","author":"JA Panepinto","year":"2013","unstructured":"Panepinto JA, Torres S, Bendo CB, McCavit TL, Dinu B, Sherman-Bien S, Bemrich-Stolz C, Varni JW (2013) PedsQL\u2122 sickle cell disease module: feasibility, reliability, and validity. Pediatr Blood Cancer 60(8):1338\u20131344","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"5877_CR13","first-page":"8","volume":"17","author":"E Vichinsky","year":"2008","unstructured":"Vichinsky E, Levine L, Bhatia S, Bojanowski J et al (2008) Endocrine dysfunctions in thalassemia. In Standards of care guidelines for thalassemia, Children\u2019s Hospital and Research Center Oakland. Indian J Endocrinol Metab 17(1):8\u201318","journal-title":"Indian J Endocrinol Metab"},{"key":"5877_CR14","doi-asserted-by":"publisher","unstructured":"Arya AD, Sachdeva A, Yadav S, Khanna VK, Arya SC (2005) Hypogonadism in thalassemia major. Blood 106(11):3844.\u00a0https:\/\/doi.org\/10.1182\/blood.V106.11.3844.3844","DOI":"10.1182\/blood.V106.11.3844.3844"},{"issue":"1","key":"5877_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1056\/NEJM199807023390102","volume":"339","author":"RJ Adams","year":"1998","unstructured":"Adams RJ, McKie VC, Hsu L, Files B, Vichinsky E, Pegelow C, Abboud M, Gallagher D, Kutlar A, Nichols FT, Bonds DR, Brambilla D (1998) Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 339(1):5\u201311","journal-title":"N Engl J Med"},{"issue":"4","key":"5877_CR16","doi-asserted-by":"publisher","first-page":"103719","DOI":"10.1016\/j.transci.2023.103719","volume":"62","author":"FSE Ebeid","year":"2023","unstructured":"Ebeid FSE (2023) The implementation of automated red blood cell exchange (erythrocytapheresis) as a treatment modality in sickle cell disease patients: Single center experience. Transfus Apher Sci 62(4):103719","journal-title":"Transfus Apher Sci"},{"issue":"4","key":"5877_CR17","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1182\/bloodadvances.2021006778","volume":"7","author":"MS Elalfy","year":"2023","unstructured":"Elalfy MS, Hamdy M, El-Beshlawy A, Ebeid FSE, Badr M, Kanter J, Inusa B, Adly AAM, Williams S, Kilinc Y, Lee D, Fradette C, Rozova A, Temin NT, Tricta F, Kwiatkowski JL (2023) Deferiprone for transfusional iron overload in sickle cell disease and other anemias: open-label study of up to 3 years. Blood Adv 7(4):611\u2013619","journal-title":"Blood Adv"},{"issue":"18","key":"5877_CR18","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1182\/bloodadvances.2017007898","volume":"1","author":"ST Chou","year":"2017","unstructured":"Chou ST, Flanagan JM, Vege S, Luban NLC, Brown RC, Ware RE, Westhoff CM (2017) Whole-exome sequencing for RH genotyping and alloimmunization risk in children with sickle cell anemia. Blood Adv 1(18):1414\u20131422","journal-title":"Blood Adv"},{"issue":"20","key":"5877_CR19","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1056\/NEJM199505183322001","volume":"332","author":"S Charache","year":"1995","unstructured":"Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, McMahon RP, Bonds DR (1995) Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med 332(20):1317\u201322","journal-title":"N Engl J Med"},{"issue":"7","key":"5877_CR20","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1182\/blood-2018-03-834440","volume":"132","author":"CT Quinn","year":"2018","unstructured":"Quinn CT (2018) l-Glutamine for sickle cell anemia: more questions than answers. Blood 132(7):689\u2013693","journal-title":"Blood"},{"issue":"2","key":"5877_CR21","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1182\/blood.V71.2.512.512","volume":"71","author":"CR Zerez","year":"1988","unstructured":"Zerez CR, Lachant NA, Lee SJ, Tanaka KR (1988) Decreased erythrocyte nicotinamide adenine dinucleotide redox potential and abnormal pyridine nucleotide content in sickle cell disease. Blood 71(2):512\u2013515","journal-title":"Blood"},{"issue":"1","key":"5877_CR22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0022-2143(97)90062-7","volume":"130","author":"Y Niihara","year":"1997","unstructured":"Niihara Y, Zerez CR, Akiyama DS, Tanaka KR (1997) Increased red cell glutamine availability in sickle cell anemia: demonstration of increased active transport, affinity, and increased glutamate level in intact red cells. J Lab Clin Med 130(1):83\u201390","journal-title":"J Lab Clin Med"},{"key":"5877_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/ajh.20336","volume":"79","author":"SK Ballas","year":"2005","unstructured":"Ballas SK, Lusardi M (2005) Hospital readmission for adult acute sickle cell painful episodes: frequency, etiology, and prognostic significance. Am J Hematol 79:17\u201325","journal-title":"Am J Hematol"},{"issue":"2","key":"5877_CR24","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/pbc.20180","volume":"44","author":"JA Panepinto","year":"2005","unstructured":"Panepinto JA, Brousseau DC, Hillery CA, Scott JP (2005) Variation in hospitalizations and hospital length of stay in children with vaso-occlusive crises in sickle cell disease. Pediatr Blood Cancer 44(2):182\u2013186","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"5877_CR25","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1203\/00006450-199607000-00007","volume":"40","author":"EK Salman","year":"1996","unstructured":"Salman EK, Haymond MW, Bayne E, Sager BK, Wiisanen A, Pitel P, Darmaun D (1996) Protein and energy metabolism in prepubertal children with sickle cell anemia. Pediatr Res 40(1):34\u201340","journal-title":"Pediatr Res"},{"issue":"11","key":"5877_CR26","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/S0891-5849(01)00480-4","volume":"30","author":"FQ Schafer","year":"2001","unstructured":"Schafer FQ, Buettner GR (2001) Redox environment of the cell as viewed through the redox state of the glutathione disulfide\/glutathione couple. Free Radic Biol Med 30(11):1191\u20131212","journal-title":"Free Radic Biol Med"},{"key":"5877_CR27","doi-asserted-by":"crossref","unstructured":"Marc Rhoads J, Wu G (2009) Glutamine, arginine, and leucine signaling in the intestine. Amino Acids 37(1):111\u2013122","DOI":"10.1007\/s00726-008-0225-4"},{"issue":"2","key":"5877_CR28","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1177\/0148607110381407","volume":"35","author":"H Xue","year":"2011","unstructured":"Xue H, Sufit AJ, Wischmeyer PE (2011) Glutamine therapy improves outcome of in vitro and in vivo experimental colitis models. JPEN J Parenter Enteral Nutr 35(2):188\u2013197","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"2","key":"5877_CR29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.cyto.2003.12.008","volume":"26","author":"K Liboni","year":"2004","unstructured":"Liboni K, Li N, Neu J (2004) Mechanism of glutamine-mediated amelioration of lipopolysaccharide-induced IL-8 production in Caco-2 cells. Cytokine 26(2):57\u201365","journal-title":"Cytokine"},{"issue":"10091","key":"5877_CR30","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0140-6736(17)30193-9","volume":"390","author":"RE Ware","year":"2017","unstructured":"Ware RE, de Montalembert M, Tshilolo L, Abboud MR (2017) Sickle cell disease. Lancet 390(10091):311\u2013323","journal-title":"Lancet"},{"key":"5877_CR31","doi-asserted-by":"publisher","unstructured":"Rigano P, De Franceschi L, Sainati L, Piga A, Piel FB, Cappellini MD, Fidone C, Masera N, Palazzi G, Gianesin B, Forni GL, Italian Multicenter Study of Hydroxyurea in Sickle Cell Anemia Investigators (2018) Real-life experience with hydroxyurea in sickle cell disease: a multicenter study in a cohort of patients with heterogeneous descent. Blood Cells Mol Dis 69:82\u201389. https:\/\/doi.org\/10.1016\/j.bcmd.2017.08.017","DOI":"10.1016\/j.bcmd.2017.08.017"},{"issue":"9","key":"5877_CR32","doi-asserted-by":"publisher","first-page":"931925","DOI":"10.3389\/fmed.2022.931925","volume":"1","author":"N Elenga","year":"2022","unstructured":"Elenga N, Loko G, Etienne-Julan M, Al-Okka R, Adel AM, Yassin MA (2022) Real-World data on efficacy of L-glutamine in preventing sickle cell disease-related complications in pediatric and adult patients. Front Med (Lausanne) 1(9):931925","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"5877_CR33","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.10.019","volume":"28","author":"MS ElAlfy","year":"2019","unstructured":"ElAlfy MS, Ebeid FSE, Kamal TM, Eissa DS, Ismail EAR, Mohamed SH (2019) Angiotensinogen M235T Gene Polymorphism is a Genetic Determinant of Cerebrovascular and Cardiopulmonary Morbidity in Adolescents with Sickle Cell Disease. J Stroke Cerebrovasc Dis 28(2):441\u2013449","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"1","key":"5877_CR34","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.arcped.2017.11.015","volume":"25","author":"V Corvest","year":"2018","unstructured":"Corvest V, Blais S, Dahmani B, De Tersant M, Etienney AC, Maroni A, Ormi\u00e8res C, Roussel A, Pondarr\u00e9 C (2018) Vasculopathie c\u00e9r\u00e9brale de l\u2019enfant dr\u00e9panocytaire\u202f: points cl\u00e9s et nouveaut\u00e9s [Cerebral vasculopathy in children with sickle cell disease: Key issues and the latest data]. Arch Pediatr 25(1):63\u201371","journal-title":"Arch Pediatr"},{"issue":"8","key":"5877_CR35","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1007\/s00431-021-04189-7","volume":"180","author":"MS Elalfy","year":"2021","unstructured":"Elalfy MS, Ibrahim AS, Ibrahim GS, Hussein HMAG, Mohammed HGE, Ebeid FSE (2021) Hidden brain iron content in sickle cell disease: impact on neurocognitive functions. Eur J Pediatr 180(8):2677\u20132686","journal-title":"Eur J Pediatr"},{"issue":"12","key":"5877_CR36","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2147\/JBM.S291394","volume":"25","author":"UO Ogu","year":"2021","unstructured":"Ogu UO, Badamosi NU, Camacho PE, Freire AX, Adams-Graves P (2021) Management of Sickle Cell Disease Complications Beyond Acute Chest Syndrome. J Blood Med 25(12):101\u2013114","journal-title":"J Blood Med"},{"key":"5877_CR37","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jpeds.2019.10.049","volume":"217","author":"JK Weisman","year":"2020","unstructured":"Weisman JK, Diamond CE, Kappa S, Nickel RS (2020) Transcranial Doppler Screening Adherence among Children with Sickle Cell Anemia Seen in the Emergency Department. J Pediatr 217:172-176.e1","journal-title":"J Pediatr"},{"issue":"11","key":"5877_CR38","doi-asserted-by":"publisher","first-page":"4334","DOI":"10.1002\/hbm.22921","volume":"36","author":"K Cohen Kadosh","year":"2015","unstructured":"Cohen Kadosh K, Krause B, King AJ, Near J, Cohen KR (2015) Linking GABA and glutamate levels to cognitive skill acquisition during development. Hum Brain Mapp 36(11):4334\u20134345","journal-title":"Hum Brain Mapp"},{"issue":"23","key":"5877_CR39","doi-asserted-by":"publisher","first-page":"e2042","DOI":"10.1212\/WNL.0000000000005644","volume":"90","author":"H Stotesbury","year":"2018","unstructured":"Stotesbury H, Kirkham FJ, K\u00f6lbel M, Balfour P, Clayden JD, Sahota S, Sakaria S, Saunders DE, Howard J, Kesse-Adu R, Inusa B, Pelidis M, Chakravorty S, Rees DC, Awogbade M, Wilkey O, Layton M, Clark CA, Kawadler JM (2018) White matter integrity and processing speed in sickle cell anemia. Neurology 90(23):e2042\u2013e2050","journal-title":"Neurology"},{"key":"5877_CR40","doi-asserted-by":"publisher","unstructured":"Sands S, Ladas EJ, Kelly KM, Weiner M, Lin M, Ndao DH, Dave A, Vahdat LT, Bender JG (2017) Glutamine for the treatment of vincristine-induced neuropathy in children and adolescents with\u00a0cancer. Support Care Cancer 25(3):701\u2013708. https:\/\/doi.org\/10.1007\/s00520-016-3441-6","DOI":"10.1007\/s00520-016-3441-6"},{"issue":"11","key":"5877_CR41","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.3390\/nu10111564","volume":"10","author":"V Cruzat","year":"2018","unstructured":"Cruzat V, Macedo Rogero M, Noel Keane K, Curi R, Newsholme P (2018) Glutamine: Metabolism and Immune Function, Supplementation and Clinical Translation. Nutrients 10(11):1564","journal-title":"Nutrients"},{"issue":"8","key":"5877_CR42","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1007\/s00277-022-04867-y","volume":"101","author":"F Jafri","year":"2022","unstructured":"Jafri F, Seong G, Jang T, Cimpeanu E, Poplawska M, Dutta D, Lim SH (2022) L. glutamine for sickle cell disease: more than reducing redox. Ann Hematol 101(8):1645\u20131654","journal-title":"Ann Hematol"},{"issue":"1","key":"5877_CR43","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.clnu.2015.01.021","volume":"35","author":"P Jegatheesan","year":"2016","unstructured":"Jegatheesan P, Beutheu S, Ventura G, Sarfati G, Nubret E, Kapel N, Waligora-Dupriet AJ, Bergheim I, Cynober L, De-Bandt JP (2016) Effect of specific amino acids on hepatic lipid metabolism in fructose-induced non-alcoholic fatty liver disease. Clin Nutr 35(1):175\u2013182","journal-title":"Clin Nutr"},{"issue":"1","key":"5877_CR44","doi-asserted-by":"publisher","first-page":"170","DOI":"10.2527\/jas.2008-1698","volume":"88","author":"S Chamorro","year":"2010","unstructured":"Chamorro S, de Blas C, Grant G, Badiola I, Menoyo D, Caraba\u00f1o R (2010) Effect of dietary supplementation with glutamine and a combination of glutamine-arginine on intestinal health in twenty-five-day-old weaned rabbits. J Anim Sci 88(1):170\u2013180","journal-title":"J Anim Sci"},{"key":"5877_CR45","doi-asserted-by":"publisher","unstructured":"Zhang Y, Lu T, Han L, Zhao L, Niu Y, Chen H (2017) L-Glutamine Supplementation Alleviates Constipation during Late Gestation of Mini Sows by Modifying the Microbiota Composition in Feces. Biomed Res Int 2017:4862861. https:\/\/doi.org\/10.1155\/2017\/4862861","DOI":"10.1155\/2017\/4862861"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05877-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-024-05877-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05877-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T05:17:56Z","timestamp":1724822276000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-024-05877-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,19]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["5877"],"URL":"https:\/\/doi.org\/10.1007\/s00277-024-05877-8","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,19]]},"assertion":[{"value":"27 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}